PMID- 33841160 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20210413 IS - 1663-9812 (Print) IS - 1663-9812 (Electronic) IS - 1663-9812 (Linking) VI - 12 DP - 2021 TI - Nicotinamide Mononucleotide Combined With Lactobacillus fermentum TKSN041 Reduces the Photoaging Damage in Murine Skin by Activating AMPK Signaling Pathway. PG - 643089 LID - 10.3389/fphar.2021.643089 [doi] LID - 643089 AB - Long-term exposure to UVB (280-320 nm) can cause oxidative skin damage, inflammatory injury, and skin cancer. Research on nicotinamide mononucleotide (NMN) and lactic acid bacteria (LAB) with regard to antioxidation, anti-inflammation, and prevention of other age-related diseases has received increasing attention. In the present study, the in vitro antioxidant analysis showed that NMN combined with Lactobacillus fermentum TKSN041 (L. fermentum TKSN041) has a high scavenging ability on hydroxyl (OH), 2, 2'-azino-bis (3-ethylbenzthiazoline-6-sulphonic acid) diammonium salt (ABTS) and 1, 1-diphenyl-2-picrylhydrazyl (DPPH), and it also possess a good total antioxidant capacity. The animal experimental results show that NMN combined with LAB maintained normal liver morphology of mice and reduced pathological damage to murine skin. NMN combined with LAB significantly increased the serum levels of total superoxide dismutase (T-SOD), catalase (CAT), and interleukin (IL)-10, but reduced the levels of malondialdehyde, advanced glycation end products, tumor necrosis factor (TNF)-alpha, and IL-6. NMN combined with LAB increased T-SOD, CAT, IL-10, Na(+)-K(+)-ATPase, and NAD(+) levels in the skin, but reduced TNF-alpha level in the skin. NMN combined with LAB increased the mRNA expression levels of SOD1, CAT, glutathione (GSH), inhibitor of NF-kappaB (IkappaB-alpha), IL-10, AMP-activated protein kinase (AMPK), adaptor protein, phosphotyros ineinteraction, PH domain and leucine zipper containing 1 (APPL1), peroxisome proliferator-activated receptor gamma co-activator-1alpha (PGC-1alpha), and forkhead transcription factor O (FOXO) in the skin and liver, but decreased the mRNA expression levels of nuclear factor (NF)-kappaBp65, TNF-alpha, IL-6, and rapamycin target protein (mTOR). NMN combined with LAB increased the protein expression levels of AMPK, IkappaB-alpha, SOD1, and CAT in the skin tissues and reduced protein expression of NF-kappaBp65. NMN combined with L. fermentum TKSN041 improved murine skin damage caused by UVB irradiation, and the protective mechanism may be related to activation of the AMPK signaling pathway. The results of this study are expected to provide a reference for preventing and the treating skin photoaging. CI - Copyright (c) 2021 Zhou, Du, Ni, Ran, Hu, Yu and Zhao. FAU - Zhou, Xianrong AU - Zhou X AD - Chongqing Collaborative Innovation Center for Functional Food, Chongqing University of Education, Chongqing, China. AD - Chongqing Engineering Research Center of Functional Food, Chongqing University of Education, Chongqing, China. AD - Chongqing Engineering Laboratory for Research and Development of Functional Food, Chongqing University of Education, Chongqing, China. FAU - Du, Hang-Hang AU - Du HH AD - Department of Plastic Surgery, Chongqing Huamei Plastic Surgery Hospital, Chongqing, China. FAU - Ni, Luyao AU - Ni L AD - Chongqing Collaborative Innovation Center for Functional Food, Chongqing University of Education, Chongqing, China. FAU - Ran, Jie AU - Ran J AD - Chongqing Collaborative Innovation Center for Functional Food, Chongqing University of Education, Chongqing, China. FAU - Hu, Jian AU - Hu J AD - Effepharm (Shanghai) Co., Ltd., Shanghai, China. FAU - Yu, Jianjun AU - Yu J AD - Effepharm (Shanghai) Co., Ltd., Shanghai, China. FAU - Zhao, Xin AU - Zhao X AD - Chongqing Collaborative Innovation Center for Functional Food, Chongqing University of Education, Chongqing, China. AD - Chongqing Engineering Research Center of Functional Food, Chongqing University of Education, Chongqing, China. AD - Chongqing Engineering Laboratory for Research and Development of Functional Food, Chongqing University of Education, Chongqing, China. LA - eng PT - Journal Article DEP - 20210325 PL - Switzerland TA - Front Pharmacol JT - Frontiers in pharmacology JID - 101548923 PMC - PMC8027253 OTO - NOTNLM OT - AMP OT - UVB OT - in vitro antioxidant OT - lactobacillus fermentum OT - nicotinamide mononucleotide OT - skin COIS- Jian Hu and Jianjun Yu were employed by Effepharm (Shanghai) Co., Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2021/04/13 06:00 MHDA- 2021/04/13 06:01 PMCR- 2021/03/25 CRDT- 2021/04/12 06:16 PHST- 2020/12/17 00:00 [received] PHST- 2021/02/15 00:00 [accepted] PHST- 2021/04/12 06:16 [entrez] PHST- 2021/04/13 06:00 [pubmed] PHST- 2021/04/13 06:01 [medline] PHST- 2021/03/25 00:00 [pmc-release] AID - 643089 [pii] AID - 10.3389/fphar.2021.643089 [doi] PST - epublish SO - Front Pharmacol. 2021 Mar 25;12:643089. doi: 10.3389/fphar.2021.643089. eCollection 2021.